July 2018 - Page 2 of 2 - CanadianCannabisWire

TuesdayJul 03, 2018 11:35 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues Advancing Innovative Drug Delivery Research Program

PreveCeutical is continuing its extensive research work on the Sol-gel CBD-based delivery system An expansion to Australia has enabled the company to run simultaneous tests on cannabis strains and delivery systems The scientific work is in line with a growing demand for cannabidiol and medicinal cannabis products Over the past few months, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has been working on the advancement of its innovative Sol-gel drug delivery research program. The focus of the research is to apply Sol-gel technology to develop cannabinoid-based therapies for the relief of symptoms associated with pain, inflammation, seizures and…

MondayJul 02, 2018 1:13 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Closes Purchase of Canadian Cannabis Campus; Facility Construction Advances

Sunniva acquires 126-acre property for cannabis production in British Columbia Construction at sibling cultivation site in California continues Company hosts VIP event at International Cannabis Business Conference, joins M&A panel discussion Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a rising cannabis producer that is gaining a solid foothold in the consumer-populated markets of California and Canada, has announced the close of its 126-acre site in British Columbia’s rural Okanagan Falls-Similkameen district located 45 kilometers (28 miles) north of the U.S.-Canada border. The 126-acre industrial-zoned property will be the site for a 740,000-square-foot state-of-the-art greenhouse capable of producing an estimated 100,000 kilograms…